Year: 2026
Type: article
Abstract: Induced pluripotent stem cell (iPSC)-based regenerative medicine holds great promise for the treatment of age-related diseases. However, it still faces numerous challenges. One critical issue is whether iPSCs, which are commonly believed to be ageless and to indefinitely self-renew in an undifferentiated state, undergo a decline in cell quality during continuous passaging, ultimately compromising their therapeutic potential. Here, we show that long-term cultured iPSCs acquire aging-like molecular and functional deterioration, including impaired DNA repair via non-homologous end joining (NHEJ), loss of cellular identity, and diminished differentiation potential. Mechanistically, decreased levels of Lamin A trigger DNA-PKcs inactivation, leading to impaired NHEJ during prolonged culture. This DNA-PKcs inactivation then suppresses DNMT3A expression via SP1/3 and induces transcriptomic signatures characteristic of aging, ultimately impairing pluripotency. Our findings establish that iPSCs undergo aging-like deterioration during extended culture through DNA damage-epigenetics crosstalk, highlighting the critical need for genomic stability monitoring. Furthermore, we identify feasible targets to improve cell quality in iPSC-based clinical applications.
Source: Advanced Science
DOI: 10.1002/advs.78797
Authors: Xiaoyu Xu(Investigation, Writing – original draft, Writing – review & editing), Mengting Wang(Investigation, Writing – review & editing), Hao Wang(Investigation, Visualization, Writing – original draft, Writing – review & editing), Jiayu Yu(Investigation), Yanxin Huang(Investigation), Li Wu(Resources), Ying Jiang(Funding acquisition), Shaorong Gao(Funding acquisition, Supervision), Zhiyong Mao(Conceptualization, Funding acquisition, Supervision, Writing – review & editing), Jiayu Chen(Conceptualization, Funding acquisition, Supervision), Yu Chen(Conceptualization, Funding acquisition, Supervision, Visualization, Writing – original draft)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $6,730
OpenAlex ID: W7236192285
